Investigating a new target for treating obesity-related insulin resistance
Official title: TP-R: a novel mediator of obesity-linked insulin resistance in humans
Funded at Omaha VA Medical Center · NIH-11073079 · Data updated 2026-11-12
This study is looking at how a specific molecule and its receptor affect weight gain and how our bodies use insulin, with the goal of finding new ways to help people with obesity improve their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Omaha VA Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project start | April 1, 2021 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| NIH project number | 5I01CX002084-05 |
| Project ID | NIH-11073079 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adults struggling with obesity and insulin resistance, particularly those with elevated levels of branched chain amino acids.
✕Less likely to help
Patients who are not affected by obesity or insulin resistance may not benefit from this research.
What this research studies
This research explores the role of thromboxane A2 (TXA2) and its receptor (TP-R) in obesity and insulin resistance. It aims to understand how TP-R influences metabolic pathways, particularly in adipose tissue, which is crucial for fat storage and amino acid metabolism. By studying the effects of TP-R on inflammation and insulin sensitivity, the research seeks to identify potential therapeutic targets for improving metabolic health in individuals with obesity. The study will utilize clinical, biochemical, and molecular methods to gather comprehensive data on these mechanisms.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for obesity-related insulin resistance, improving metabolic health for many patients.
How similar studies have gone: While the specific approach of targeting TP-R is novel, related research has shown promise in understanding the metabolic roles of adipose tissue in insulin resistance.
Where this research is happening
-
Omaha VA Medical Center
Omaha, United States Active
Researchers
- Principal investigator: Viswanathan, Saraswathi — Omaha VA Medical Center
- Study coordinator: Viswanathan, Saraswathi
Related research
Other NIH-funded projects on the same topics.
-
Profiling immune cells to find early inflammation clues in kids with obesity and insulin resistance
This project looks at how immune cells in children with obesity may show early inflammatory changes linked to insulin resistance.
-
Vitamin D and early-life risk of obesity and insulin resistance
This project tests whether giving vitamin D during pregnancy helps prevent children from becoming obese or insulin-resistant.
-
Obesity's role in blood pressure and insulin resistance in PCOS
This work explores how excess body fat and male hormones affect blood pressure and insulin resistance in women with PCOS.
-
Investigating the role of vitamin D in obesity and insulin resistance in young veterans
This study is looking at how not getting enough vitamin D during pregnancy might lead to weight gain and health problems in young veterans and their children, and it hopes to find out if taking vitamin D supplements while pregnant can help prevent these issues.
-
Investigating the link between obesity, insulin resistance, and asthma severity
This study is looking at how insulin resistance, pre-diabetes, and diabetes impact asthma control in people with obesity who have asthma, especially those getting weight loss surgery, to help understand how these conditions might affect their breathing and overall health.
-
Investigating the role of a peptide in obesity and insulin resistance
This study is looking at how a substance called endothelin-1 might make it harder for your body to use insulin properly, which can lead to type II diabetes, especially in people who are overweight, and it hopes to find out if blocking certain receptors can help improve insulin sensitivity and blood sugar levels.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.